South Africa’s HIV response, once considered a global model, is rapidly deteriorating due to the sudden withdrawal of US funding—particularly from Pepfar, which had supported essential treatment, prevention, and research initiatives.

Guest: Professor Francois Venter is a clinician researcher at Wits University. He led a large Pepfar programme until 2012 and has had a support role since then. He and his unit do not receive Pepfar, CDC or USAID funding